Covance Inc.

Shareholder Corporation Litigation

Rigrodsky & Long, P.A. Announces Investigation Of Covance Inc. (NYSE: CVD) Buyout

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Covance Inc. (“Covance” or the “Company”) (NYSE: CVD) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Laboratory Corporation of America Holdings (“LabCorp”) (NYSE: LH), in a transaction valued at approximately $6.1 billion.

Under the terms of the agreement, public shareholders of Covance will receive $75.76 in cash and 0.2686 LabCorp shares for each share of Covance they own. Based on LabCorp’s closing stock price on October 31, 2014, Covance shareholders would have received consideration valued at approximately $105.12 per share.

The investigation concerns whether Covance’s board of directors failed to adequately shop the Company and obtain the best possible value for Covance’s shareholders before entering into an agreement with LabCorp.

If you own the common stock of Covance and purchased your shares before November 3, 2014, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242; by e-mail to info@rl-legal.com.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.

Attorney advertising.  Prior results do not guarantee a similar outcome.